Gene · 7170
Papers3,595
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,595
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diffuse Eruptive Spitz Nevus With Somatic TPM3::ALK Fusion Confirmed Across Anatomically Distinct Lesions. | Pigment Cell Melanoma Res | 2026 | 42827359 | PubTator, text mining | PubMed |
| A chemoresistance-associated proliferation gene signature identified by single-cell and machine learning analysis predicts prognosis in high-grade serous ovarian carcinoma. | Transl Oncol | 2026 | 42696959 | PubTator, text mining | PubMed |
| Adult Sarcomas with NTRK Fusions: Clinicopathologic and Genomic Heterogeneity. | Cancers (Basel) | 2026 | 42588743 | PubTator, text mining | PubMed |
| Longitudinal Molecular Characterization of a Rare TPM3::PDGFRB-Rearranged Myeloid/Lymphoid Neoplasm With Late CNL-Like Neutrophilic Evolution. | Eur J Haematol | 2026 | 42549531 | PubTator, text mining | PubMed |
| Research progress on the role and mechanism of STIM and Orai protein-mediated store-operated calcium entry in cardiovascular diseases. | Channels (Austin) | 2026 | 42503223 | PubTator, text mining | PubMed |
| Distinct conformational dynamics of the type-2 Angiotensin II receptor bound to Angiotensin II and Angiotensin (1-7). | Sci Rep | 2026 | 42477346 | PubTator, text mining | PubMed |
| Evolutionarily conserved hydrophobicity and sterics in TM3/TM4 balance Orai1 pore opening. | Protein Sci | 2026 | 42438363 | PubTator, text mining | PubMed |
| Cancer of Unknown Primary Most Suggestive of Colorectal Origin With Microsatellite Instability-high Status and High Tumor Mutation Burden Including NTRK Fusion. | Cancer Diagn Progn | 2026 | 42388581 | PubTator, text mining | PubMed |
| In vitro and in silico modelling of ROS1-positive non-small cell lung cancer reveals fusion-dependent tyrosine kinase inhibitor responses. | Mol Oncol | 2026 | 42338217 | PubTator, text mining | PubMed |
| Structural basis for lysophosphatidic acid recognition and atypical Gαq coupling by LPAR5. | Proc Natl Acad Sci U S A | 2026 | 42313925 | PubTator, text mining | PubMed |
| Plasma autoantibodies as novel risk markers for stroke: A nested case-control study of the JPHC study. | Clin Chim Acta | 2026 | 42225204 | PubTator, text mining | PubMed |
| Seipin-defined ER sites undergo distinct enrichment of factors for the biogenesis of sterol ester rich lipid droplets. | iScience | 2026 | 42088363 | PubTator, text mining | PubMed |
| Znhit1-mediated H2A.Z deposition governs transcriptional programs essential for oocyte meiotic progression. | Development | 2026 | 42083516 | PubTator, text mining | PubMed |
| Structural Characterization of the Interaction of γ-Secretase with GSM-1 Modulator. | ACS Chem Neurosci | 2026 | 42068555 | PubTator, text mining | PubMed |
| The transmembrane IL-15 isoform expressed on human melanoma cells triggers modulatory effects on tumor progression upon stimulation with the soluble IL-15Rα chain. | Front Immunol | 2026 | 42064067 | PubTator, text mining | PubMed |
| Integrative single-cell RNA-seq and ATAC-seq profiling identifies NTN5 +LSAMP + myoblasts as mediators of impaired embryonic myogenesis. | Zool Res | 2026 | 42011759 | PubTator, text mining | PubMed |
| Molecular landscape and biomarker associations of functional NTRK fusions: a real-world retrospective cohort study across solid tumors. | Transl Cancer Res | 2026 | 41969448 | PubTator, text mining | PubMed |
| Inflammatory Myofibroblastic Tumor of the Lung: A Rare Find in an Elderly Female. | J Investig Med High Impact Case Rep | 2026 | 41914218 | PubTator, text mining | PubMed |
| Minimal residual disease assessment through ctDNA facilitates tailored immunotherapy in MSI-high, NTRK1-fusion pancreatic adenocarcinoma. | Oncologist | 2026 | 41913057 | PubTator, text mining | PubMed |
| Structures of the human glucose-6-phosphate transporter provide insights into its transport cycle and substrate recognition. | PLoS Biol | 2026 | 41911224 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7170/papers